Invasive pneumococcal disease in England and Wales: Vaccination implications

被引:97
作者
Sleeman, K
Knox, K
George, R
Miller, E
Waight, P
Griffiths, D
Efstratiou, A
Broughton, K
Mayon-White, RT
Moxon, ER
Crook, DW [1 ]
机构
[1] John Radcliffe Hosp, Dept Microbiol, Oxford Vaccine Grp, Oxford OX3 9DU, England
[2] Univ Oxford, Wellcome Trust Ctr Epidemiol Infect Dis, Oxford OX1 2JD, England
[3] Publ Hlth Lab Serv, London NW9 5EQ, England
关键词
D O I
10.1086/317924
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Knowledge of the epidemiology of invasive pneumococcal disease (IPD) will aid in planning the use of pneumococcal vaccines. A United Kingdom (UK)-based surveillance in England and Wales (1995-1997) of 11,528 individuals with IPD and a local enhanced surveillance in the Oxford (UK) area (1995-1999) have been analyzed. IPD has a high attack rate in children, with 37.1-48.1 cases per 100,000 infants <1 year old per year, and in older persons, with 21.2-36.2 cases per 100,000 persons >65 years old per year, for England, Wales, and Oxford. The 7-valent conjugate vaccine includes serotypes causing less than or equal to 79% of IPD in children <5 years old, but only 66% in adults >65 years old. The data also indicate that IPD varies by serotype, age, and country, emphasizing that the epidemiology of IPD is heterogeneous and requires continued surveillance.
引用
收藏
页码:239 / 246
页数:8
相关论文
共 63 条
[1]   Streptococcus pneumonia capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory [J].
Åhman, H ;
Käyhty, H ;
Lehtonen, H ;
Leroy, O ;
Froeschle, J ;
Eskola, J .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (03) :211-216
[2]  
[Anonymous], 1999, Pediatr Infect Dis J, V18, pS32
[3]  
[Anonymous], 1985, Br Med J (Clin Res Ed), V290, P778
[4]  
[Anonymous], 1999, WKLY EPIDEMIOL REC
[5]   T-CELL REGULATION OF THE ANTIBODY-RESPONSE TO BACTERIAL POLYSACCHARIDE ANTIGENS - AN EXAMINATION OF SOME GENERAL-CHARACTERISTICS AND THEIR IMPLICATIONS [J].
BAKER, PJ .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 :S44-S48
[6]   Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children [J].
Black, S ;
Shinefield, H ;
Fireman, B ;
Lewis, E ;
Ray, P ;
Hansen, JR ;
Elvin, L ;
Ensor, KM ;
Hackell, J ;
Siber, G ;
Malinoski, F ;
Madore, D ;
Chang, I ;
Kohberger, R ;
Watson, W ;
Austrian, R ;
Edwards, K .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) :187-195
[7]  
BURMAN LA, 1985, REV INFECT DIS, V7, P133
[8]  
Butler JC, 1998, LANCET, V351, P1961, DOI 10.1016/S0140-6736(05)78647-5
[9]  
*CDCP, 2000, EP PREV VACC PREV DI, P249
[10]  
*CDCP NAT CTR INF, 1999, ACT BACT COR SURV AB